Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$0.45 - $0.8 $37,552 - $66,760
-83,450 Closed
0 $0
Q1 2022

Apr 26, 2022

SELL
$0.66 - $1.23 $74,355 - $138,571
-112,660 Reduced 57.45%
83,450 $68,000
Q4 2021

Jan 10, 2022

SELL
$1.09 - $2.55 $172,830 - $404,328
-158,560 Reduced 44.71%
196,110 $224,000
Q3 2021

Oct 26, 2021

SELL
$2.06 - $5.34 $1,236 - $3,204
-600 Reduced 0.17%
354,670 $887,000
Q2 2021

Jul 27, 2021

BUY
$2.88 - $5.64 $18,172 - $35,588
6,310 Added 1.81%
355,270 $1.06 Million
Q1 2021

May 05, 2021

BUY
$3.4 - $7.97 $472,056 - $1.11 Million
138,840 Added 66.08%
348,960 $1.23 Million
Q1 2021

Apr 16, 2021

SELL
$3.4 - $7.97 $455,396 - $1.07 Million
-133,940 Reduced 38.93%
210,120 $1.08 Million
Q4 2020

Jan 27, 2021

BUY
$4.11 - $7.51 $5,343 - $9,763
1,300 Added 0.38%
344,060 $1.63 Million
Q3 2020

Oct 23, 2020

BUY
$3.28 - $5.93 $395,371 - $714,802
120,540 Added 54.24%
342,760 $1.67 Million
Q2 2020

Jul 28, 2020

BUY
$3.18 - $15.54 $78,418 - $383,216
24,660 Added 12.48%
222,220 $722,000
Q1 2020

Apr 14, 2020

BUY
$2.36 - $5.6 $80,051 - $189,952
33,920 Added 20.73%
197,560 $1.01 Million
Q4 2019

Jan 16, 2020

BUY
$3.94 - $5.76 $156,378 - $228,614
39,690 Added 32.02%
163,640 $746,000
Q3 2019

Oct 11, 2019

SELL
$4.84 - $7.25 $7,260 - $10,875
-1,500 Reduced 1.2%
123,950 $758,000
Q2 2019

Jul 15, 2019

SELL
$5.56 - $7.85 $12,232 - $17,270
-2,200 Reduced 1.72%
125,450 $764,000
Q1 2019

Apr 24, 2019

BUY
$5.32 - $7.18 $679,098 - $916,527
127,650 New
127,650 $709,000

About CHEMBIO DIAGNOSTICS, INC.


  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Penbrook Management LLC Portfolio

Follow Penbrook Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penbrook Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penbrook Management LLC with notifications on news.